DMT is N,N-dimethyltryptamine, a short-acting tryptamine hallucinogen that occurs naturally in several plant species and is also produced synthetically. The Drug Enforcement Administration's Diversion Control Division records that DMT was placed in Schedule I of the Controlled Substances Act when that Act passed in 1971, and that DMT has no approved medical use in the United States.
Two properties separate DMT from the hallucinogens it is grouped with. The effects arrive within seconds of inhalation and resolve within 30 to 45 minutes, which is a fraction of an LSD experience. And DMT is inactive by mouth on its own, which is why the plant brew ayahuasca pairs it with monoamine oxidase inhibitors that keep the molecule intact long enough to reach the brain.
Federal forensic laboratories have received more than 11,800 DMT reports since 1999, and DMT has been encountered in all 50 states, Washington, D.C., and Puerto Rico.
What Is DMT?
DMT is a Schedule I tryptamine hallucinogen built on the tryptamine core structure, with two methyl groups substituted for the two hydrogen atoms on the terminal nitrogen of the ethylamine side chain. The British chemist Richard Manske first synthesized DMT in 1931, and human use of DMT-containing plants in religious practice spans several hundred years, per the DEA drug and chemical evaluation summary for DMT.
The DEA identifies 2 supply routes for illicit DMT: extraction from plant material and synthesis in clandestine laboratories, with internet sales serving as a distribution channel in the United States. Forensic seizure volumes track that supply. The DEA's National Forensic Laboratory Information System recorded 589 DMT reports in 2016, 1,061 in 2021, 799 in 2022, 905 in 2023, 817 in 2024, and more than 380 in 2025 with reports still pending. DMT is also the active hallucinogen in the South American brews ayahuasca and hoasca, which the DEA records as its ceremonial and religious form. What the molecule does after it reaches the brain is the same in either case.
How Does DMT Affect the Brain and Body?
DMT acts as an agonist at serotonin 5-HT2A and 5-HT2C receptors, producing intense visual hallucinations, depersonalization, auditory distortions, and an altered sense of time and body image. Smith, Randall L. and colleagues demonstrated DMT's agonist activity at the 5-HT2A and 5-HT2C receptors in their 1998 study in Pharmacology, Biochemistry, and Behavior, and the DEA records the psychological effects alongside a distinct physiological profile that includes hypertension, increased heart rate, agitation, seizures, dilated pupils, nystagmus, dizziness, and ataxia.
The cardiovascular and neurological effects are the ones that send people to emergency departments. American Association of Poison Control Centers data cited by the DEA associate coma and respiratory arrest with DMT exposures. Call 911 for anyone who is unresponsive, having a seizure, or breathing slowly or irregularly after taking DMT, and contact Poison Help at 1-800-222-1222 for guidance on any hallucinogen exposure. The Food and Drug Administration's Adverse Event Reporting System recorded 44 cases involving DMT between 2003 and 2025, of which 37 were classified as serious and 10 involved death, with 2025 producing the largest annual count at 14 cases. NIDA adds a short-term physical profile shared across psychedelics: headaches, abdominal pain, nausea, vomiting, high blood pressure, rapid heartbeat, trembling, and diarrhea. How long any of this lasts depends entirely on how DMT enters the body.
How Long Does a DMT Experience Last?
A DMT experience lasts 30 to 45 minutes when the drug is smoked, snorted, or given intravenously, and 4 to 6 hours when it is taken orally in ayahuasca alongside monoamine oxidase inhibitors. The DEA reports the rapid onset and 30-to-45-minute resolution for the non-oral routes, and the intense-but-brief profile is what the agency identifies as the drug's specific appeal.
Route determines duration because route determines whether the molecule survives first-pass metabolism. The table below sets the documented time course of each route beside the mechanism that produces it.
| Route | Onset | Duration or elimination | Why |
| Smoked or snorted | Seconds | Resolves within 30 to 45 minutes | Bypasses gut monoamine oxidase entirely |
| Intravenous (clinical research only) | Seconds | Effects resolve within 30 to 45 minutes; plasma half-life 4.8 to 19.0 minutes | Direct systemic delivery, rapid metabolism to indole-3-acetic acid |
| Oral, DMT alone | Negligible | Negligible | Oral bioavailability is very poor without enzyme inhibition |
| Oral, as ayahuasca | Not characterized in the cited review | Peaks at 90 to 120 minutes, resolves within 4 to 6 hours | Harmala alkaloids inhibit monoamine oxidase, so DMT stays intact |
Brevity is not safety. A 30-minute effect invites repeat administration inside a single session, and the ayahuasca route introduces a pharmacological interaction that the smoked route does not.
What Is Ayahuasca and How Does It Interact With Antidepressants?
Ayahuasca is a brew combining DMT-containing leaves with harmala alkaloids that inhibit monoamine oxidase, and that enzyme inhibition creates a documented risk of serotonin syndrome when the brew is combined with selective serotonin reuptake inhibitors. Callaway, James C. and Grob, Charles S. described that combination in their 1998 paper "Ayahuasca preparations and serotonin reuptake inhibitors: a potential combination for severe adverse interactions" in the Journal of Psychoactive Drugs.
The mechanism is additive serotonergic load. Harmine and harmaline reversibly inhibit monoamine oxidase A, with tetrahydroharmine contributing less, which raises serotonin and norepinephrine levels while making oral DMT active. An SSRI blocks serotonin reuptake on top of that inhibition, and the two mechanisms stack. Anyone taking a prescribed serotonergic antidepressant or a monoamine oxidase inhibitor therefore faces a drug interaction rather than a drug experience. The separate question of whether repeated DMT use produces addiction has a different answer.
Is DMT Addictive?
DMT is not documented to produce the compulsive-use pattern that defines addiction, and tolerance to psychedelic drugs develops quickly. NIDA's overview of psychedelic and dissociative drugs reports that the limited research available on psilocybin and LSD does not show those drugs typically leading to addiction, and that tolerance to psychedelics develops quickly enough that people take escalating amounts to reach the same effect. No comparable body of research exists for DMT.
Three qualifications keep that answer from becoming reassurance. Hallucinogen use disorder is a real diagnosis with a measured prevalence: NIDA reports that 0.2 percent of people aged 12 or older, about 493,000 people, met criteria for it in 2020. Psychological consequences persist after use stops, and NIDA distinguishes brief flashbacks, which last seconds or minutes and occur within a week of taking a substance, from hallucinogen persisting perception disorder, in which longer episodes recur years later. And use is rising sharply. Hallucinogen use among people aged 12 or older increased from 2.7 percent, or 7.6 million people, in 2021 to 3.6 percent, or 10.4 million people, in 2024, per the National Survey on Drug Use and Health. Rising use across a class of drugs whose hallucinogen addiction profile includes persistent perceptual disorders is a clinical problem regardless of how the dependence question resolves.
Who Uses DMT?
DMT users are concentrated among college students and young adults, matching the demographic pattern the DEA records for Schedule I hallucinogens generally. The agency also notes religious and ceremonial use of DMT-containing preparations internationally, which is a separate user population from the recreational one.
The age skew has a practical consequence, because young adults use hallucinogens at nearly twice the rate of the general population. The 2024 National Survey on Drug Use and Health counted past-year hallucinogen use at 6.8 percent among adults aged 18 to 25, against 3.6 percent for people aged 12 or older, 3.4 percent among adults 26 or older, and 1.6 percent among adolescents. A difficult experience in a young adult therefore raises a diagnostic question alongside a toxicological one, and psychiatric evaluation is the part of assessment that answers it. Legal status shapes how that population obtains the drug.
Is DMT Legal in the United States?
DMT is illegal to manufacture, distribute, or possess in the United States as a Schedule I controlled substance under the Controlled Substances Act. Schedule I is the classification reserved for substances with no currently accepted medical use and a high potential for abuse, and the DEA confirms DMT has no approved medical use in the United States.
Two nuances follow from the plant origin. DMT is present in ordinary plant material, so the legal exposure attaches to extraction, possession, and distribution of the controlled substance rather than to botany. And DMT is under active clinical investigation as an experimental treatment, which is a research designation rather than a change in legal status. A person facing a possession charge alongside a substance use problem is dealing with two systems at once, and treatment addresses one of them directly.
How Is Problematic DMT Use Treated?
Treatment for problematic DMT use combines medical assessment of the cardiovascular and neurological effects with psychiatric evaluation for persistent perceptual and mood symptoms, then behavioral therapy for the use pattern itself. No medication is approved to treat hallucinogen use disorder, so the clinical work is diagnostic and psychotherapeutic.
The psychiatric half is where DMT cases differ from other substance cases. Persistent perceptual changes, panic, and depersonalization outlast the drug, and those symptoms respond to structured treatment rather than to waiting. Valley Spring Recovery Center evaluates co-occurring psychiatric and substance use conditions together through its dual diagnosis treatment in Norwood, New Jersey, where psychiatric evaluation and outpatient therapy run in the same treatment plan. Admissions staff at (855) 924-5320 complete a free, confidential pre-assessment at any hour. Readers comparing DMT with the other drugs in its class will find the pharmacology of LSD addiction and a wider survey of the 8 common hallucinogens and psychedelic drugs useful next.
What Are the Most Common Questions About DMT?
The 6 questions below cover duration, detection, legality, and terminology facts people search most about DMT. Each answer stands alone in 40 words or fewer.
What Does DMT Stand For?
DMT stands for N,N-dimethyltryptamine. The molecule is a tryptamine formed by substituting two methyl groups for the two hydrogen atoms on the terminal nitrogen of tryptamine's ethylamine side chain, per the DEA.
How Long Does DMT Stay in Your System?
Effects resolve within 30 to 45 minutes when DMT is smoked or snorted, per the DEA. Intravenous DMT has an elimination half-life of 4.8 to 19.0 minutes, per van der Heijden and colleagues' 2025 review in Clinical Pharmacokinetics.
Is DMT the Same as Ayahuasca?
No. DMT is the hallucinogenic molecule; ayahuasca is a brew that combines DMT-containing plant leaves with harmala alkaloids that inhibit monoamine oxidase so the DMT survives oral administration.
Can DMT Cause Death?
The FDA's Adverse Event Reporting System recorded 44 DMT cases from 2003 to 2025, of which 10 involved death. Coma and respiratory arrest are associated with DMT exposures, so call 911 for anyone unresponsive or breathing abnormally and Poison Help at 1-800-222-1222 for exposure guidance.
What Schedule Is DMT?
Schedule I. DMT entered Schedule I of the Controlled Substances Act when the Act passed in 1971 and has no approved medical use in the United States, per the DEA.
Does DMT Cause Withdrawal?
No withdrawal syndrome is documented for DMT. Tolerance to psychedelics develops rapidly, and hallucinogen use disorder affected about 493,000 people aged 12 or older in 2020, per NIDA.